Large-scale preparation of UV-inactivated SARS coronavirus virions for vaccine antigen

27Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In general, a whole virion serves as a simple vaccine antigen and often essential material for the analysis of immune responses against virus infection. However, to work with highly contagious pathogens, it is necessary to take precautions against laboratory-acquired infection. We have learned many lessons from the recent outbreak of severe acute respiratory syndrome (SARS). In order to develop an effective vaccine and diagnostic tools, we prepared UV-inactivated SARS coronavirus on a large scale under the strict Biosafety Level 3 (BSL3) regulation. Our protocol for large-scale preparation of UV-inactivated SARS-CoV including virus expansion, titration, inactivation, and ultracentrifugation is applicable to any newly emerging virus we might encounter in the future. © 2008 Humana Press.

Cite

CITATION STYLE

APA

Tsunetsugu-Yokota, Y. (2008). Large-scale preparation of UV-inactivated SARS coronavirus virions for vaccine antigen. Methods in Molecular Biology, 454, 119–126. https://doi.org/10.1007/978-1-59745-181-9_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free